Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-25 @ 7:40 PM
NCT ID:
NCT04191135
Group ID:
EG002
Title:
Pembrolizumab + Carboplatin + Gemcitabine
Description:
This arm includes participants who randomized following completion of the induction period. Participants continued to receive both carboplatin AUC 2 with gemcitabine 1000 mg/m\^2 intravenously on Days 1 and 8 of each 21-day cycle in addition to pembrolizumab 200 mg intravenously on Day 1 of each 21-day cycle in the post-induction period.
Deaths Number Affected:
54
Deaths Number At Risk:
None
Serious Number Affected:
32
Serious Number At Risk:
133
Other Number Affected:
128
Other Number At Risk:
133
Study:
NCT04191135
Results Section:
NCT04191135
Adverse Events Module:
NCT04191135